Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sanofi AATD Inc.
Sponsor

Sanofi AATD Inc.

United States 450 Water Street, 02141-2288, United States

About the sponsor

Sanofi AATD Inc. focuses its clinical research on alpha-1 antitrypsin deficiency with a specific emphasis on emphysema, reflecting interest in lung disease linked to inherited protein deficiency and progressive respiratory impairment.

  • AATD-associated emphysema
  • Respiratory disease
  • Inherited pulmonary disorders

The sponsor’s trial portfolio is centered on therapeutic approaches aimed at addressing the clinical burden of alpha-1 antitrypsin deficiency in adults with chronic lung involvement.

About Specializations

Sanofi AATD Inc. runs clinical trials in conditions such as Alpha-1 antitrypsin deficiency, Emphysema, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Alpha-1 antitrypsin deficiency+1

Not recruiting
InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Alpha-1-Proteinase Inhibitor Immunoglobulin G Fusion Protein, Recombinant
  • Sponsor:Sanofi AATD Inc.

Alpha-1 antitrypsin deficiency+1

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Human Alpha-1-Proteinase Inhibitor Immunoglobulin G Fusion Protein, Recombinant
  • Sponsor:Sanofi AATD Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.